Barri Blauvelt

      Barri Blauvelt

      Demonstrating Impact of Upstream Omnichannel Strategy on Downstream Results

      by Barri M. Blauvelt, CEO, Innovara   Upstream strategy used to be the domain of health care marketing. Today, it involves commercial, clinical research, access management,...
      Barri Blauvelt -

      Recent Articles

      Ellipses Pharma Presents Design of Newly Initiated Phase 1/2a Trial of Vosilasarm (EP0062) at SABCS

      Industry News

      Clarify Health Recognized for Innovation in Patient Recruitment in Clinical Trials

      Industry News

      Dr. Ravi Karra Joins Advanced Clinical to Accelerate Global Growth and Deliver Innovative Oncology Trials

      Look Who’s On the Move!

      Nimble Therapeutics names Pete Gough as Chief Scientific Officer

      Look Who’s On the Move!

      Memgen Reports Results From Its First-In-Human Clinical Trial of MEM-288 in Solid Tumors Refractory to Checkpoint Inhibitors at SITC 2022

      Industry News

      Spirita Oncology, LLC Initiates a Phase 1 Clinical Trial of the Anti-Cancer Agent E6201 in Combination with Dabrafenib in Patients with Central Nervous System...

      Industry News

      Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis

      Industry News

      Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)

      Regulatory Affairs

      Ferring Receives U.S. FDA Approval for REBYOTA® (fecal microbiota, live-jslm) – A Novel First-in-Class Microbiota-Based Live Biotherapeutic

      Regulatory Affairs

      insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer

      Look Who’s On the Move!

      Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer

      Look Who’s On the Move!

      ReCode Therapeutics Appoints Trisha Millican to Board of Directors

      Look Who’s On the Move!

      Amulet Capital Partners Acquires United Vein & Vascular Centers

      Industry News

      Aldeyra Therapeutics Submits New Drug Application to the U.S. Food and Drug Administration for Reproxalap for the Treatment of Signs and Symptoms of Dry...

      Regulatory Affairs

      Gate Neurosciences Doses First Subject in a Translational EEG Biomarker Study of Apimostinel, a Rapid-Acting Treatment for Acute Depressive Disorders

      Industry News

      2021 © Copyright - TPMG

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.